NM_001034853.2(RPGR):c.823G>A (p.Gly275Ser) is a missense variant predicted to cause substitution of glycine by serine at amino acid 275. This variant is absent from hemizygous individuals in gnomAD v4.1.0 (PM2_Supporting). This variant has been reported in at least 4 families, with 1 proband exhibiting a family history consistent with X-linked inheritance, functional vision impairment by age 30 years, decreased cone and rod electroretinogram responses, optic disc pallor, attenuation of vessels, pigmentary retinopathy, abnormal autofluorescence, reduced visual acuity, and abnormal color vision, which together are specific for RPGR-related retinopathy (4 points, PMID: 17480003, PP4). This finding has been combined with reports of the variant in at least 2 additional apparently unrelated probands meeting the requirement of some functional vision impairment in affected males by age 30, with decreased or absent cone and/or rod electroretinogram responses (PMID: 17480003, PMID: 16969763, PS4_Supporting). The variant has been reported to segregate with the phenotype through 12 affected meioses in 2 families, meeting the ClinGen X-linked IRD VCEP PP1_Strong requirement of ≥4 meioses in >1 family (PP1_Strong; PMID: 17480003). At least 4 other missense variants at the same codon (p.Gly275Arg, p.Gly275Cys, p.Gly275Val, and p.Gly275Asp) have been reported in association with retinal disease, however, all of them have a higher Grantham score than this variant, so PM5 is not met. The computational predictor REVEL gives a score of 0.968, which is above the ClinGen X-linked IRD VCEP threshold of >0.932 and predicts a damaging effect on RPGR function (PP3_strong). Fluorescence microscopy-based localization assay performed with the p.Gly275Ser mutant and wild-type RPGR exogenously expressed as GFP-fusion proteins by RPE1 cells showed complete loss of localization to the primary cilia (PMID: 30622176). Tag-based RPGR pull-down from HEK293T cells using anti-Flag beads followed by western blotting-based detection of endogenous PDE6D, RPGRIP1L, or INPP5 showed that the mutant had complete loss of interaction with INPP5E and RPGRIP1L, further indicating a damaging effect on protein function (PMID: 30622176; PS3_Supporting). In summary, this variant meets the criteria to be classified as pathogenic for RPGR-related retinopathy based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPGR Version 1.0.0; PS3_Supporting, PS4_Supporting, PM2_Supporting, PP1_Strong, PP3_Strong, and PP4. (date of approval 05/16/2025).